Register Here

Lead Sponsor

Parexel

Featured Executive Sponsors

IQVIA
Advara

Executive Sponsors

Castor
Clinical Ink
Elligo Health Research
PRA – now ICON
Labcorp
PhysIQ
Quest
Reify Health
Verily

Associate Sponsors

Be The Partner
BBK
Complion
Current Health
Datacubed Health
ERT
Florence Health
Greenphire
HealthiVibe
Inato
IPM.ai
Javara
King-Devick Technologies
Langland
Lifelink Systems
Lightship
mdgroup
Medable
Medidata
Medocity
MMG
Objective GI
ObvioHealth
PPD
Saama
Science 37
THREAD
WCG
Withings
YPrime

Exhibiting Companies

DataArt Solutions
MedPoint Digital
muv
Portamedic
Pro-Ficiency
Shimmer Sensing
Tasso

Supporting Sponsor

Cerner
Clincierge
Kantar

2021 Supporting Partner

Savvy

2021 Media Partners

Applied Clinical Trials
Big 4 Bio
Clinical Leader
Pharmalicensing

Making Innovation Stick
in a Post COVID World

Celebrating 10 Years of Reporting on Decentralized Clinical Trials

 

DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patient feedback.

The concept of DPHARM was founded by Pfizer and Janssen who continue to play a key role on the steering committee to deliver a highly relevant and engaging program. DPHARM is the conference where a wide range of pharma companies report on innovation to advance clinical trials.

What to Expect in 2021

The fast-forward button was pressed this past year to accommodate patients and PIs and DPHARM will challenge and report on what will stick to benefit a wide range of therapeutic areas post-pandemic.


2021 Visionary Keynote

 


2021 Special Guest Speakers

 

Patient Keynote Speaker

Featuring: Data Science Gurus

Featuring: Global Clinical Operation Leaders

2021 Pharma Companies Reporting from the Trenches

  • BMS
  • Boehringer Ingelheim
  • Eli Lilly
  • Regeneron
  • GSK
  • Takeda
  • Janssen
  • Novartis
  • Pfizer
  • Sanofi
  • LEO Pharma
  • Merck
  • Gilead

2021 Topics Include

  • Decentralized Clinical Trials
  • What Will Stick Post COVID
  • Enabling Digital Transformation for Clinical Trials
  • Advances in Data Science
  • AI and Machine Learning
  • Platform Trials
  • Patient Experience Data
  • Transforming the Entire R&D Value Chain
  • Disrupting Protocol Developments
  • Unpacking Unconscious Bias and its Link to Innovation
  • Collaborations Worth Sharing
  • Innovative Digital and Patient-Centered Solutions
  • Integrating Clinical Research and Clinical Care

DPHARM Idol Disrupt

DPHARM Idol Disrupt is a series of quick fire presentations where you see bold and daring startups pitch their disruptive technologies to the most discerning judges. The Q&A provides amazing shared learnings on how to properly assess new technologies. This section of DPHARM kicks off with an update from the 2020 Winner, King-Devick Technologies. 

2021 DPHARM Idol Disrupt Judges


Esther Dyson, Executive Founder, Way to Wellville

Cindy Geoghegan, Patient Advocate

Adama Ibrahim, eMBA, Director, Digital Solutions, Global Drug Development, Novartis

Sarah Krüg, CEO, Cancer101

Craig Lipset, MBA, Advisor and Founder, Clinical Innovation Partners

Mark Travers, PhD, MBA, Vice President, Head of GCTO Regions, Monitoring Excellence, Global Operations and eTMF, Merck

 

DPHARM Commitment 


  • DPHARM combines TED-style talks with fireside chats, quick fires, panels and demos presentations showcasing innovations from leading Pharma R&D practitioners and from other industries.
  • DPHARM underscores the promise and challenge of innovation in advancing drug development.
  • DPHARM features new models and collaborations to get therapeutics to patients faster.
  • DPHARM features the full spectrum of clinical research options and utilizes insights more appropriately.
  • DPHARM is dedicated to challenging creative solutions and finding a way to implement them.
  • DPHARM explores to whom companies are being disruptive and to gain a better understanding of the impact on clinical trials.

 


All attendees must be FULLY vaccinated against COVID-19 to attend DPHARM in person. Join the conversation early and become part of the DPHARM community by following us on LinkedIn and by following the conference hashtag #DPHARM2021.  Registration is open and take advantage of the early rates and group rates. Thank you.

Sincerely,

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith Sands
Executive Director, Strategic Partnerships

Jennifer Moran B&W1

Kate Woda
Conference Director

Elizabeth Bard B&W-47

Elizabeth Bard
Senior Strategic Partnership Manager

Adam Kolanko
Strategic Partnership Manager

Meg

Meg Gould
Senior Conference Planner

Allyson Adams
Senior Marketing Manager

Efrosini Zambas
Meeting Planner

 

The Most Advanced Conference
on Challenging New Ideas for Clinical Trials

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave


Testimonials

  • "Wow! What a great event. So many interesting people and CRAACO is such a brilliant movement. I am inspired by so many of the people and presentations that I saw. Congrats...bringing together amazing people at conferences with a mission."

    - Dave Bjork, Patient Advocate

  • "DPharm is truly a first class event and we are thrilled to have been a part of it. We extracted tremendous value and look forward to expanding our role in future events. Best event of the year."

    - Ryan Tubbs, Microsoft

  • "Loved the conference. I learned so much and can’t wait to share lessons learned with my colleagues at the Scleroderma Foundation."

    - Joan Meissner, Patient Advocate

  • "Really great presentations (almost Ted-talk like set up); enjoyed the information sharing and inspirational patient speakers (also great that there were patients/advocates attending as well)."

    - Danielle DeVico, Biogen

  • "Patient Keynote was very touching. I liked the richness of the content. Greatly produced."

    - Hassan Kadhim, BMS

  • "DPharm is the go to place to connect with innovators in pharma research."

    - Joe Kim, Eli Lilly

  • "An informative meeting with great networking. I like the style of presentations, the cutting edge presentations and opening with inspirational stories."

    - Megan McBride, Janssen

  • "Thanks for making it happen again. Great event, growing attendance, and more importantly increasing quality."

    - Tomasz Sablinski, MD, PhD, Transparency Life Sciences

  • "Unencumbered access to some incredibly brilliant minds, brought together by the obvious enjoyment they have in collaborating. I found the event quite inclusive. Thank you for making this a valuable learning experience."

    - Marilyn Pratt, Medidata

  • "Congratulations on a very successful conference."

    - Chandra Ramanathan, Bayer HealthCare, LLC

  • "Thank you! It was great...as usual!"

    - Solomon Babani, BioPharma Solutions

  • "What an amazing meeting. So impressed!"

    - John Brownstein, PhD, Boston Children’s Hospital

  • "Thank you for putting together such a great event. It was a pleasure working with each of you.It was a great experience."

    - Amy Ripston, 4G Clinical

  • "Thanks and congrats again for a great DPharm2016, proud to have been part of this years edition."

    - Bert Hartog, Janssen

  • "Thank you for making DPharm a valuable learning experience."

    - Marilyn Pratt, Medidata Solutions

  • "Dpharm was a must attend event for those looking at embedding Systemic Thinking and disruptive innovation into their work models."

    - Michelle Shogren, Bayer

  • "I love coming back to DPharm as the 2014 edition changed my life. It was my first time at DPharm and prior to my attendance, I was working on innovation related to the way we design clinical trials. I recall being absolutely amazed by the spirit of collaboration. After the conference was over, I spent my Saturday connecting with speakers and attendees on Linkedin, thinking: I want to be part of this community! Two years later, my dream came true...I come back to find respected colleagues that became friends and collaborations, to exchange ideas and learn from each other!"

    - Attendee, DPharm 2016